Will Tesla Stock Go Up In 2026?
EV giant Tesla (NASDAQ:TSLA) has, somewhat surprisingly, undershot the broader…
Sell
29
AGN.CX Quote, Financials, Valuation and Earnings
Last price:
$0.08
Seasonality move
:
31.42%
Day range:
$0.08 - $0.08
52-week range:
$0.06 - $0.12
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.57x
Volume:
27.8K
Avg. volume:
13.8K
1-year change:
6.67%
Market cap:
$2.7M
Revenue:
--
EPS (TTM):
-$0.06
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Algernon Health, Inc. has 3103.13% upside to fair value with a price target of -- per share.
AGN.CX vs. S&P 500
-
Over the past 5 trading days, Algernon Health, Inc. has overperformed the S&P 500 by 1.03% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Algernon Health, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Algernon Health, Inc. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Algernon Health, Inc. reported revenues of --.
Earnings Growth
-
Algernon Health, Inc. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Algernon Health, Inc. reported earnings per share of -$0.02.
Enterprise value:
2.7M
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
-2.01x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$25.6K
Return On Assets:
-44.51%
Net Income Margin (TTM):
--
Return On Equity:
-96.85%
Return On Invested Capital:
-96.85%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-05-31 | 2024-05-31 | 2025-05-31 | 2024-05-31 | 2025-05-31 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -$65.4K | -$34.5K | -$25.6K | -$6.1K | -$8.7K | |
| Operating Income | -$6.5M | -$3M | -$1.8M | -$465.7K | -$583.2K | |
| EBITDA | -$6.4M | -$2.9M | -$1.7M | -$459.6K | -$574.6K | |
| Diluted EPS | -$0.57 | -$0.18 | -$0.06 | $0.07 | -$0.02 | |
| Period Ending | 2021-05-31 | 2022-05-31 | 2023-05-31 | 2024-05-31 | 2025-05-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $6.4M | $1.6M | $587K | $687K | $233.9K | |
| Total Assets | $11.6M | $6.9M | $6.1M | $3.9M | $4.9M | |
| Current Liabilities | $1.9M | $1.3M | $2.4M | $1.9M | $2.9M | |
| Total Liabilities | $1.9M | $1.3M | $2.4M | $1.9M | $3.1M | |
| Total Equity | $9.7M | $5.6M | $3.7M | $2M | $1.7M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-05-31 | 2024-05-31 | 2025-05-31 | 2024-05-31 | 2025-05-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$3.5M | -$2.7M | -$1.3M | -$1.8M | -$174.5K | |
| Cash From Investing | -$103K | $2.3M | $155.7K | $2.3M | $175K | |
| Cash From Financing | $3.1M | $542.2K | $628.2K | $7.5K | -- | |
| Free Cash Flow | -$3.6M | -$2.7M | -$1.3M | -$1.8M | -$174.5K | |
AGN.CX
Sector
Market Cap
$2.7M
--
Price % of 52-Week High
65.31%
--
Dividend Yield
0%
--
Shareholder Yield
-28.76%
--
1-Year Price Total Return
6.67%
--
Beta (5-Year)
1.326
--
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$0.08
200-day SMA
Sell
Level
$0.08
Bollinger Bands (100)
Buy
Level
0.06 - 0.08
Chaikin Money Flow
Sell
Level
-5.9M
20-day SMA
Sell
Level
$0.08
Relative Strength Index (RSI14)
Sell
Level
48.57
ADX Line
Buy
Level
18.7
Williams %R
Neutral
Level
-50
50-day SMA
Sell
Level
$0.08
MACD (12, 26)
Sell
Level
0.00
25-day Aroon Oscillator
Sell
Level
-28
On Balance Volume
Sell
Level
-3.9M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-12.2822)
Sell
CA Score
(Annual)
Level (-3.3788)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (5)
Sell
Ohlson Score
Level (10.4646)
--
Piotroski F Score
(Annual)
Level (--)
Buy
Quality Ratio Score
Level (2)
Buy
Fundamental Score
Level (1)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Algernon Health, Inc. is a drug re-purposing company that investigates safe, already approved drugs, including naturally occurring compounds, for new disease applications, moving them into new human trials, developing new formulations and seeking new regulatory approvals in global markets. It specifically investigates compounds that have never been approved in the U.S. or Europe to avoid off label prescription writing. The company was founded on January 22, 2015 and is headquartered in Vancouver, Canada.
Stock Forecast FAQ
In the current month, AGN.CX has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The AGN.CX average analyst price target in the past 3 months is --.
-
Where Will Algernon Health, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Algernon Health, Inc. share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Algernon Health, Inc.?
Analysts are divided on their view about Algernon Health, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Algernon Health, Inc. is a Sell and believe this share price will drop from its current level to --.
-
What Is Algernon Health, Inc.'s Price Target?
The price target for Algernon Health, Inc. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is AGN.CX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Algernon Health, Inc. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of AGN.CX?
You can purchase shares of Algernon Health, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Algernon Health, Inc. shares.
-
What Is The Algernon Health, Inc. Share Price Today?
Algernon Health, Inc. was last trading at $0.08 per share. This represents the most recent stock quote for Algernon Health, Inc.. Yesterday, Algernon Health, Inc. closed at $0.08 per share.
-
How To Buy Algernon Health, Inc. Stock Online?
In order to purchase Algernon Health, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get AGN.CX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
AGN.CX
Sector
P/E ratio
--
--
PEG ratio
--
--
P/B ratio
1.57x
--
Price / LTM sales
--
--
Growth Metrics
AGN.CX
Sector
Revenue growth
--
--
Earnings growth
-133.33%
--
Revenue (5-year growth)
--
--
Earnings forecast
--
--
Profitability
AGN.CX
Sector
Profitability FY 2024
-$26.6K
--
Return on invested capital
-96.85%
--
Return on assets
-44.51%
--
Return on equity
-96.85%
--
Earnings Date
Last Earnings Date
Dec
16
Next Earnings Date
Dec
16
Estimated Next Earnings Date
Mar
17
Balance Sheet
AGN.CX
Sector
Total cash
$88.2K
--
Short term investments
--
--
Total assets
$3.9M
--
Long term debt
--
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
What Are the Best AI Power Stocks?
As the construction of AI infrastructure accelerates, the gap between…
Is IONQ The Best Quantum Stock to Buy?
Riding a wave of investor enthusiasm for the technology, quantum…
Stock Ideas
Sell
49
Is NVDA Stock a Buy?
Market Cap: $4.3T
P/E Ratio: 60x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
71
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
39
SMX alert for Dec 16
SMX (Security Matters) Plc [SMX] is down 13.76% over the past day.
Sell
33
ZBIO alert for Dec 16
Zenas BioPharma, Inc. [ZBIO] is down 0.15% over the past day.
Sell
38
HUT alert for Dec 16
Hut 8 Corp. [HUT] is up 2.17% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
